| Dr Jonah Anyaogu Ulu Ezieme, MD | |
|
1060 First Colonial Rd, Virginia Beach, VA 23454-3002 | |
| (757) 395-2323 | |
| (757) 827-2255 |
| Full Name | Dr Jonah Anyaogu Ulu Ezieme |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 27 Years |
| Location | 1060 First Colonial Rd, Virginia Beach, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023050515 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 023968 (Louisiana) | Secondary |
| 208M00000X | Hospitalist | 0101240068 (Virginia) | Secondary |
| 207R00000X | Internal Medicine | 0101240068 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sentara Virginia Beach General Hospital | Virginia beach, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sentara Medical Group | 8921903923 | 1058 |
News Archive
Researchers at the UCLA Jonsson Comprehensive Cancer Center analyzed gene-expression patterns in the most aggressive prostate cancer grade group - known as Gleason grade group 5 - and found that this grade of cancer can actually be subdivided into four subtypes with distinct differences.
Access Pharmaceuticals, Inc., a biopharmaceutical company specializing in products for cancer and supportive care signed a $30 million supply agreement for MuGard with RHEI Pharmaceuticals, Inc., a specialty pharmaceutical company focused on bringing proprietary medicines to the China market. Access will ensure manufacturing capacity of up to a minimum of $30 million of product in the licensed territories.
By 2017, the global electrophysiology mapping and ablation devices market is likely to achieve a value of $2.1 billion, according to a new report on companiesandmarkets.com. An ageing population, an increased number of diagnoses and several clinical studies have encouraged market growth.
PET scans and cognitive tests have suggested that Alzheimer's disease patients with genetically modified tissue inserted directly into their brains show a reduction in the rate of cognitive decline and increased metabolic activity in the brain, according to a study published in the April 24, 2005 online issue of the journal Nature Medicine by researchers at the University of California, San Diego (UCSD) School of Medicine.
› Verified 7 days ago
| Entity Name | Sentara Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265485270 PECOS PAC ID: 8921903923 Enrollment ID: O20031203000466 |
News Archive
Researchers at the UCLA Jonsson Comprehensive Cancer Center analyzed gene-expression patterns in the most aggressive prostate cancer grade group - known as Gleason grade group 5 - and found that this grade of cancer can actually be subdivided into four subtypes with distinct differences.
Access Pharmaceuticals, Inc., a biopharmaceutical company specializing in products for cancer and supportive care signed a $30 million supply agreement for MuGard with RHEI Pharmaceuticals, Inc., a specialty pharmaceutical company focused on bringing proprietary medicines to the China market. Access will ensure manufacturing capacity of up to a minimum of $30 million of product in the licensed territories.
By 2017, the global electrophysiology mapping and ablation devices market is likely to achieve a value of $2.1 billion, according to a new report on companiesandmarkets.com. An ageing population, an increased number of diagnoses and several clinical studies have encouraged market growth.
PET scans and cognitive tests have suggested that Alzheimer's disease patients with genetically modified tissue inserted directly into their brains show a reduction in the rate of cognitive decline and increased metabolic activity in the brain, according to a study published in the April 24, 2005 online issue of the journal Nature Medicine by researchers at the University of California, San Diego (UCSD) School of Medicine.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jonah Anyaogu Ulu Ezieme, MD 1060 First Colonial Rd, Virginia Beach, VA 23454-3002 Ph: (757) 395-2323 | Dr Jonah Anyaogu Ulu Ezieme, MD 1060 First Colonial Rd, Virginia Beach, VA 23454-3002 Ph: (757) 395-2323 |
News Archive
Researchers at the UCLA Jonsson Comprehensive Cancer Center analyzed gene-expression patterns in the most aggressive prostate cancer grade group - known as Gleason grade group 5 - and found that this grade of cancer can actually be subdivided into four subtypes with distinct differences.
Access Pharmaceuticals, Inc., a biopharmaceutical company specializing in products for cancer and supportive care signed a $30 million supply agreement for MuGard with RHEI Pharmaceuticals, Inc., a specialty pharmaceutical company focused on bringing proprietary medicines to the China market. Access will ensure manufacturing capacity of up to a minimum of $30 million of product in the licensed territories.
By 2017, the global electrophysiology mapping and ablation devices market is likely to achieve a value of $2.1 billion, according to a new report on companiesandmarkets.com. An ageing population, an increased number of diagnoses and several clinical studies have encouraged market growth.
PET scans and cognitive tests have suggested that Alzheimer's disease patients with genetically modified tissue inserted directly into their brains show a reduction in the rate of cognitive decline and increased metabolic activity in the brain, according to a study published in the April 24, 2005 online issue of the journal Nature Medicine by researchers at the University of California, San Diego (UCSD) School of Medicine.
› Verified 7 days ago
Haidr Agha, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1157 First Colonial Rd, Ste 200, Virginia Beach, VA 23454 Phone: 757-623-0005 Fax: 757-389-5383 | |
Howard Courtenay Harrison Sr., MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1101 First Colonial Rd, Suite 101, Virginia Beach, VA 23454 Phone: 757-496-9020 Fax: 757-481-0638 | |
Vincent Lee, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 5516 Virginia Beach Blvd, Virginia Beach, VA 23462 Phone: 757-473-3969 | |
Dr. Sue Beth Hudson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 802 Newtown Rd, Virginia Beach, VA 23462 Phone: 757-497-0606 Fax: 757-497-0411 | |
Dr. Rosario Devera Hipol, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 701 Independence Cir Ste 102, Virginia Beach, VA 23455 Phone: 757-499-6395 Fax: 757-499-8026 | |
Dr. James Richard Miller, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1101 First Colonial Rd Ste 300, Virginia Beach, VA 23454 Phone: 757-395-1760 Fax: 757-756-5148 |